A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B

Sponsor
Beijing Friendship Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03108794
Collaborator
Beijing YouAn Hospital (Other), The First Hospital of Jilin University (Other), Henan Provincial People's Hospital (Other), Beijing Ditan Hospital (Other), First Affiliated Hospital of Xinjiang Medical University (Other), LanZhou University (Other), The Second Affiliated Hospital of Chongqing Medical University (Other), West China Hospital (Other), Taiyuan No.3 Hospital (Other), Hebei Medical University Third Hospital (Other), Shengjing Hospital (Other), Tianjin Third Central Hospital (Other), Peking University First Hospital (Other), Peking Union Medical College Hospital (Other), The Affiliated Hospital Of Southwest Medical University (Other), Shanghai Public Health Clinical Center (Other), Ruijin Hospital (Other), First Affiliated Hospital Xi'an Jiaotong University (Other), Xiangya Hospital of Central South University (Other), Beijing Tiantan Hospital (Other), Wuhan University (Other), The First Affiliated Hospital of Kunming Medical College (Other), The Affiliated Hospital of Xuzhou Medical University (Other), The Affiliated Hospital of Yanbian University (Other), First Affiliated Hospital of Chongqing Medical University (Other), The Fouth Hospital of Qinghai province (Other), Weifang Medical University (Other), Hunan Provincial People's Hospital (Other), The Second Hospital of Hebei Medical University (Other), Xixi Hospital of Hangzhou (Other), General Hospital of Ningxia Medical University (Other), Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology (Other), Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital (Other), Peking University People's Hospital (Other), Nanfang Hospital of Southern Medical University (Other), The Affiliated Hospital Of Guizhou Medical University (Other), Guizhou Provincial People's Hospital (Other), Hainan General Hospital (Other), The Second Hospital of Shandong University (Other), The First Affiliated Hospital of Shanxi Medical University (Other), Fifth Hospital of Shijiazhuang City (Other), Yan'an University Affiliated Hospital (Other), Infectious Disease Hospital of Wuhai (Other), Logistics University of Chinese People's Armed Police Forces (Other), People's Hospital of Changji Hui Autonomous Prefecture,Xinjiang (Other)
200,000
45
162
4444.4
27.4

Study Details

Study Description

Brief Summary

CR-HepB registry started in June 30,2012 to collect HBV cases from general hospitals or specialized hospitals for infectious diseases in mainland China. Demographics, diagnosis, laboratory test results, family history and prescriptions were recorded. The main criteria for registration is HBsAg-positivity more than 6 months, and these patients will receive followed-up visits every three to six months.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This web-based database was launched on June 30, 2012 and consists of tertiary or secondary hospitals with special interest and expertise on managing hepatitis B patients across mainland China. The main inclusion criteria for this registration are HBsAg-positivity ≥ 6 months, HBeAg positive or negative, with or without cirrhosis, either treatment-naïve or treatment experienced. At the first time of data entry, demographics, medical history, virology, biochemistry and hematology results, radiology reports, diagnosis and treatment information were recorded. Then the registered patients received standard of care and follow-up every 3 to 6 months. On each visit, virological, biochemical, and radiological reports, as well as clinical progress were recorded.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    200000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B
    Actual Study Start Date :
    Jun 30, 2012
    Anticipated Primary Completion Date :
    Dec 31, 2022
    Anticipated Study Completion Date :
    Dec 31, 2025

    Arms and Interventions

    Arm Intervention/Treatment
    Immune tolerance phase

    Immune tolerance phase is diagnosed based on the presence of high serum levels of HBV-DNA, hepatitis B e antigen (HBeAg), but normal or minimally elevated serum alanine aminotransferase (ALT), and normal liver or only minimal histological activity and scant fibrosis.

    HBeAg positive CHB

    HBeAg positive CHB is defined as those with HBsAg positive for more 6 months, HBeAg positive, high HBV DNA, elevated serum levels of ALT and histological activity.

    HBeAg negative CHB

    HBeAg negative CHB is defined as those with HBeAg negative, anti-HBe positive, lower serum HBV DNA levels and histological necroinflammation and fibrosis.

    Inactive HBsAg carriers

    Inactive HBsAg carriers was defined as those with HBsAg positive than 6 months, with low HBV DNA and persistently normal ALT, without evidence of cirrhosis.

    Compensated cirrhosis

    Diagnosis of compensated cirrhosis can be made if one of the following criteria was met: by liver histology: Ishak fibrosis stage 5-6 or METAVIR F4. endoscopy-proven gastroesophageal varices, afrter excluding non-cirrhotic portal hypertension. at least 2 features of cirrhosis: irregular liver surface, granular or nodular liver parenchyma, with or without splenomegaly (spleen thickness > 4.0cm or > 5 rib units) on ultrasound ,CT or MRI; PLT<100×109/L without other causes; Serum album in<35 g/L or INR>1.3 or PT prolongs>3s; LSM>13 kpa (ALT<5×ULN).

    Decompensated cirrhosis

    Decompensated cirrhosis was diagnosed based on the presence of ascites, bleeding esophageal varices and/or hepatic encephalopathy in cirrhotic patients.

    Hepatocellular carcinoma

    Diagnosis of hepatocellular carcinoma(HCC)can be established when one of the following one of the following 2 criteria:(1)in cirrhotic patients with nodules of 1cm or larger with typical features of HCC ( arterial enhancement with washout in venous or delay phase) on 2 radiological studies or with 1 radiological study and elevation of serum AFP; or(2)histological evidence of HCC.

    Outcome Measures

    Primary Outcome Measures

    1. Rate of liver-related events after antiviral therapy [10 years]

      Rates of cirrhosis,decompensation and hepatocellular carcinoma with or without antiviral therapy

    Secondary Outcome Measures

    1. The HBV DNA undetectable rate with or without antiviral therapy [10 years]

    2. HBeAg loss and seroconversion rates with or without antiviral therapy [10 years]

    Other Outcome Measures

    1. HBsAg loss and seroconversion rates with or without antiviral therapy [10 years]

    2. Quality of life [10 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • HBsAg-positivity over a continuous six months.

    The core exclusion criteria are: 1) HCC patients for their treatment mainly depends on surgical operation and interventional therapy, but not the antiviral therapy; 2) patients who are unable or unwilling to provide informed consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Beijing Ditan Hospital Beijing Beijing China 100015
    2 Peking Union Medical College Hospital Beijing Beijing China 100032
    3 Peking University First Hospital Beijing Beijing China 100034
    4 Peking University People's Hospital Beijing Beijing China 100044
    5 Beijing Tiantan Hospital Beijing Beijing China 100050
    6 Beijing Youan Hospital Beijing Beijing China 100069
    7 The Second Affiliated Hospital of Chongqing Medical University Chongqing Chongqing China 400010
    8 The First Affiliated Hospital of Chongqing Medical University Chongqing Chongqing China 400016
    9 Lanzhou University Second Hospital Lanzhou Gansu China 730030
    10 The First Hospital of Lanzhou University Lanzhou Gansu China 730099
    11 Nanfang Hospital, Southern Medical University Guangzhou Guangdong China 510515
    12 The Affiliated Hospital of Guizhou Medical University Guiyang Guizhou China 550004
    13 Guizhou provincial people's hospital Guiyang Guizhou China
    14 Hainan General Hospital Haikou Hainan China 570311
    15 The Second Hospital of Hebei Medical University Shijiazhuang Hebei China 050000
    16 The Fifth Hospital of Shijiazhuang Shijiazhuang Hebei China 050021
    17 The Third Hospital of Hebei Medical University Shijiazhuang Hebei China 050051
    18 Henan Provincial People's Hospital Zhengzhou Henan China 450003
    19 Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology Wuhan Hubei China 430022
    20 Zhongnan Hospital of Wuhan University Wuhan Hubei China 430071
    21 Hunan Provincial People's Hospital Changsha Hunan China 410005
    22 Xiangya Hospital Central South University Changsha Hunan China 410008
    23 Infectious Disease Hospital of Wuhai Wuhai Inner Mongolia China 016099
    24 The Affiliated Hospital of Xuzhou Medical University Xuzhou Jiangsu China 221006
    25 First Hospital of Jilin University Changchun Jilin China 130021
    26 The Affiliated Hospital of Yanbian University Yanbian Jilin China 133000
    27 Shengjing Hospital of China Medical University Shenyang Liaoning China 110004
    28 General Hospital of Ningxia Medical University Yinchuan Ningxia China 70004
    29 The Second Hospital of Shandong University Jinan Shandong China 250033
    30 Affiliated Hospital of Weifang Medical University Weifang Shandong China 261031
    31 Shanghai Ruijin Hospital Shanghai Shanghai China 200025
    32 Shanghai Public Health Clinical Center Shanghai Shanghai China 201508
    33 The First Affiliated Hospital of Shanxi Medical University Taiyuan Shanxi China 030001
    34 Taiyuan No.3 Hospital Taiyuan Shanxi China 030012
    35 First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shanxi China 710061
    36 Yanan University Affiliated Hospital Yanan Shanxi China 716000
    37 West China Hospital of Sichuan University Chengdu Sichuan China 610041
    38 The Affiliated Hospital of Southwest Medical University Luzhou Sichuan China 646099
    39 Affiliated Hospital, Logistics University of People's Armed Police Force Tianjin Tianjin China 300163
    40 Tianjin Third Central Hospital Tianjin Tianjin China 610041
    41 People's Hospital of Changji Hui Autonomous Prefecture,Xinjiang Changji Xinjiang China 831118
    42 First Affiliated Hospital of Xinjiang Medical University Urumqi Xinjiang China 830054
    43 Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital Urumqi Xinjiang China 830099
    44 First Affiliated Hospital of Kunming Medical University Kunming Yunnan China 650032
    45 Xixi Hospital of Hangzhou Hangzhou Zhejiang China 310023

    Sponsors and Collaborators

    • Beijing Friendship Hospital
    • Beijing YouAn Hospital
    • The First Hospital of Jilin University
    • Henan Provincial People's Hospital
    • Beijing Ditan Hospital
    • First Affiliated Hospital of Xinjiang Medical University
    • LanZhou University
    • The Second Affiliated Hospital of Chongqing Medical University
    • West China Hospital
    • Taiyuan No.3 Hospital
    • Hebei Medical University Third Hospital
    • Shengjing Hospital
    • Tianjin Third Central Hospital
    • Peking University First Hospital
    • Peking Union Medical College Hospital
    • The Affiliated Hospital Of Southwest Medical University
    • Shanghai Public Health Clinical Center
    • Ruijin Hospital
    • First Affiliated Hospital Xi'an Jiaotong University
    • Xiangya Hospital of Central South University
    • Beijing Tiantan Hospital
    • Wuhan University
    • The First Affiliated Hospital of Kunming Medical College
    • The Affiliated Hospital of Xuzhou Medical University
    • The Affiliated Hospital of Yanbian University
    • First Affiliated Hospital of Chongqing Medical University
    • The Fouth Hospital of Qinghai province
    • Weifang Medical University
    • Hunan Provincial People's Hospital
    • The Second Hospital of Hebei Medical University
    • Xixi Hospital of Hangzhou
    • General Hospital of Ningxia Medical University
    • Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology
    • Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital
    • Peking University People's Hospital
    • Nanfang Hospital of Southern Medical University
    • The Affiliated Hospital Of Guizhou Medical University
    • Guizhou Provincial People's Hospital
    • Hainan General Hospital
    • The Second Hospital of Shandong University
    • The First Affiliated Hospital of Shanxi Medical University
    • Fifth Hospital of Shijiazhuang City
    • Yan'an University Affiliated Hospital
    • Infectious Disease Hospital of Wuhai
    • Logistics University of Chinese People's Armed Police Forces
    • People's Hospital of Changji Hui Autonomous Prefecture,Xinjiang

    Investigators

    • Principal Investigator: Jidong Jia, Doctor, Beijing Friendship Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Jidong Jia, Liver Research Center, Beijing Friendship Hospital
    ClinicalTrials.gov Identifier:
    NCT03108794
    Other Study ID Numbers:
    • CR-HepB
    First Posted:
    Apr 11, 2017
    Last Update Posted:
    Nov 6, 2017
    Last Verified:
    Nov 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jidong Jia, Liver Research Center, Beijing Friendship Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 6, 2017